| Name | Title | Contact Details |
|---|
Fi Sales is a Saint Charles, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
New York Blood Center is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Biorez is dedicated to helping patients return to full activity sooner and safer following debilitating ligament and tendon injuries. We have developed the BioBrace™ scaffold, a new implant technology to reinforce tendon and ligament repairs and to facilitate tissue regeneration. Through our proprietary open porous architecture, and use of biomaterials, the BioBrace™ has been engineered to provide a high degree of bio-inductivity to promote rapid tissue regeneration, a biomechanical profile to reinforce repairs throughout the full healing profile, and full absorption overtime to fully restore the anatomy to its normal state. Early pre-clinical work suggests the BioBrace will deliver on the promise of a superior tissue scaffold to accelerate rehabilitation, regenerate functional tissue, and improve overall outcomes. Biorez is a VC-backed startup located in New Haven, CT.
Reflexion Health is a digital healthcare company dedicated to transforming traditional medicine and improving clinical outcomes by using innovative technology solutions to deliver patient-centered care at reduced costs. VERA™, Reflexion Health’s signature solution, is an FDA-cleared Virtual Exercise Rehabilitation Assistant that detects motion and remotely monitors the effectiveness of prescribed physical therapy in real-time. VERA brings the guidance of a physical therapist into the home to coach and motivate patients through recovery from joint replacement surgery or as a preventative therapy to reduce falls.
Pulse Biosciences is a novel medical therapy company bringing to market its proprietary CellFX™ Nano-Pulse Stimulation™ (NPS™) platform. The Company`s CellFX NPS platform provides a novel, precise, non-thermal, treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing acellular tissue. NPS`s unique mechanism of action disrupts the functions of internal cell structures while maintaining the outer cell membrane initiating a cascade of events within the cell that results in regulated cell death.